Lv3
351 积分 2021-10-22 加入
ASP7266, a novel antibody against human TSLPR, in the treatment of allergic disease
4天前
已完结
ASP7266, a Novel Antibody against Human Thymic Stromal Lymphopoietin Receptor for the Treatment of Allergic Diseases
4天前
已完结
Targeting the NRG1/HER3 pathway in tumor cells and cancer-associated fibroblasts with an anti-neuregulin 1 antibody inhibits tumor growth in pre-clinical models of pancreatic cancer
24天前
已完结
Efficacy of Zenocutuzumab in NRG1 Fusion–Positive Cancer
26天前
已完结
Molecular and hydrodynamic properties of human epidermal growth factor receptor HER2 extracellular domain and its homodimer: Experiments and multi-scale simulations
1个月前
已完结
HER2-targeted therapies beyond breast cancer — an update
1个月前
已完结
Dual EGFR-VEGF Pathway Inhibition: A Promising Strategy for Patients With EGFR-Mutant NSCLC
1个月前
已完结
Treatment Strategies for Non-Small Cell Lung Cancer with Common EGFR Mutations: A Review of the History of EGFR TKIs Approval and Emerging Data
1个月前
已完结
Different Characteristics of Direct Factor Xa Inhibitors: In Vitro Comparative Studies of Rivaroxaban and Apixaban
2个月前
已关闭
In Vitro Evaluation of Apixaban, a Novel, Potent, Selective and Orally Bioavailable Factor Xa Inhibitor
2个月前
已完结
皖公网安备34019202002308
